261 related articles for article (PubMed ID: 25990480)
1. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
Fawzy M; Mesbah Y
Arch Gynecol Obstet; 2015 Dec; 292(6):1267-71. PubMed ID: 25990480
[TBL] [Abstract][Full Text] [Related]
2. Triptorelin for the treatment of adenomyosis: A multicenter observational study of 465 women in Russia.
Andreeva E; Absatarova Y
Int J Gynaecol Obstet; 2020 Dec; 151(3):347-354. PubMed ID: 32815156
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
Hirata T; Izumi G; Takamura M; Saito A; Nakazawa A; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
Gynecol Endocrinol; 2014 Oct; 30(10):726-9. PubMed ID: 24905725
[TBL] [Abstract][Full Text] [Related]
4. Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study.
Cosson M; Querleu D; Donnez J; Madelenat P; Konincks P; Audebert A; Manhes H
Fertil Steril; 2002 Apr; 77(4):684-92. PubMed ID: 11937116
[TBL] [Abstract][Full Text] [Related]
5. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
[TBL] [Abstract][Full Text] [Related]
6. Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
Ota K; Takahashi T; Shiraishi S; Mizunuma H
J Obstet Gynaecol Res; 2018 Sep; 44(9):1787-1792. PubMed ID: 29998482
[TBL] [Abstract][Full Text] [Related]
7. Dienogest in the treatment of endometriosis: systematic review.
Andres Mde P; Lopes LA; Baracat EC; Podgaec S
Arch Gynecol Obstet; 2015 Sep; 292(3):523-9. PubMed ID: 25749349
[TBL] [Abstract][Full Text] [Related]
8. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
Ceccaroni M; Clarizia R; Liverani S; Donati A; Ceccarello M; Manzone M; Roviglione G; Ferrero S
Gynecol Endocrinol; 2021 Oct; 37(10):930-933. PubMed ID: 34036845
[TBL] [Abstract][Full Text] [Related]
9. Comparison of dienogest versus combined oral contraceptive pills in the treatment of women with adenomyosis: A randomized clinical trial.
Hassanin AI; Youssef AA; Yousef AM; Ali MK
Int J Gynaecol Obstet; 2021 Aug; 154(2):263-269. PubMed ID: 33454995
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.
Osuga Y; Fujimoto-Okabe H; Hagino A
Fertil Steril; 2017 Oct; 108(4):673-678. PubMed ID: 28911934
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Matsushima T; Akira S; Yoneyama K; Takeshita T
Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
[TBL] [Abstract][Full Text] [Related]
12. Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial.
Ferrero S; Venturini PL; Gillott DJ; Remorgida V
Reprod Biol Endocrinol; 2011 Jun; 9():88. PubMed ID: 21693037
[TBL] [Abstract][Full Text] [Related]
13. Expression of Lewis (b) blood group antigen interferes with oral dienogest therapy among women with adenomyosis.
Xue J; Li L; Li F; Li N; Li T; Li C
J Reprod Immunol; 2020 Feb; 137():103079. PubMed ID: 31927399
[TBL] [Abstract][Full Text] [Related]
14. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Kusuki I; Yamanaka K; Suganuma I
Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232
[TBL] [Abstract][Full Text] [Related]
15. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
Niu X; Luo Q; Wang C; Zhu L; Huang L
Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
17. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis.
Takeuchi A; Koga K; Miyashita M; Makabe T; Sue F; Harada M; Hirata T; Hirota Y; Fujii T; Osuga Y
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():157-161. PubMed ID: 27865118
[TBL] [Abstract][Full Text] [Related]
18. Effects of triptorelin versus placebo on the symptoms of endometriosis.
Bergqvist A; Bergh T; Hogström L; Mattsson S; Nordenskjöld F; Rasmussen C
Fertil Steril; 1998 Apr; 69(4):702-8. PubMed ID: 9548161
[TBL] [Abstract][Full Text] [Related]
19. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
20. Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial.
Wang W; Ma X; Zhang W; Li Z; Wang Y; Yu Z; Zhang C; Hong L; Luo R; Xing H; Wang W; Yue Q; Wei J; Zhang M; Wang S
Trials; 2020 Apr; 21(1):364. PubMed ID: 32345377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
